Answers are grounded in this paper and cite their sources.
Background Understanding of immune responses and biomarker discovery in African savanna elephants ( Loxodonta africana ) has been limited due to the paucity of transcriptomic resources. Therefore, this study aimed to generate a high-quality whole blood transcriptome for this species using both short- and long-read sequencing data and develop a workflow for transcriptome assembly in non-model species. To determine the highest quality assembly, multiple transcriptome assemblies were generated and evaluated using combinations of short- and long-read sequencing data, together with reference-guided ( StringTie, StringTie2 and StringTie2 annotation-guided) and de novo ( rnaSPAdes , Trinity and RNA-Bloom2 ) assembly approaches. Results Paired-end short-read next-generation sequencing data were generated using the MGI platform, while long-read sequencing data were produced using the third-generation Oxford Nanopore Technologies platform. From the assembly tools compared in this study, StringTie2 with annotation-guided assembly produced the highest-quality transcriptome. This assembly exhibited high transcript continuity, low levels of unannotated transcripts, extensive functional annotation, and a BUSCO completeness score of 98.4%. Functional characterisation represented diverse biological processes, molecular functions, cellular components, and pathways relevant to immune and cellular regulation. Conclusion These findings support the use of this whole blood transcriptome as a reference resource for future studies related to disease in African savanna elephants. The transcriptome and associated annotations provide a foundation for future gene expression, functional genomics, and genome annotation research in this endangered species.
No takes yet. Share an insight, caveat, or question.
Engel et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: